Refine your search

Your search returned 8 results.

Sort
Results
1.
Liraglutide 3.0 mg efficacy and safety by baseline BMI in the SCALE Diabetes Trial: post-hoc analysis.=698 \\ MedStar authors:
  • Aroda, Vanita
Year: 2015
Citation:
  • Unpublished 2015 Sep 14
Institution:
  • MedStar Health Research Institute
Form of publication:
  • Conference
All authors:
  • Hemmingsson JU, Aroda V, Davies M, Bays H, et al
Local accession number:
  • 2015_3
2.
Similar incidence of gastrointestinal side effects between IDegLira and Non-Glucagon-Like Peptide-1 receptor agonist comparators MedStar authors:
  • Aroda, Vanita
Year: 2015
Citation:
  • Unpublished 2015 Sep 14
Institution:
  • MedStar Health Research Institute
Form of publication:
  • Conference
All authors:
  • Aroda V, Vilsboll T, Jaeckel E, et al
Local accession number:
  • 2015_3
3.
Similar incidence of gastrointestinal side effects between IDegLira and Non-Glucagon-Like Peptide-1 receptor agonist comparators MedStar authors:
  • Aroda, Vanita
Year: 2015
Citation:
  • Unpublished 2015 Sep 14
Institution:
  • MedStar Health Research Institute
Form of publication:
  • Conference
All authors:
  • Aroda V, Vilsboll T, Jaeckel E, et al
Local accession number:
  • 2015_3
4.
Upper and/or lower GI adverse events with long- vs short-acting GLP-1 receptor agonists: incidence, co-incidence, effects on HbA1c and weight MedStar authors:
  • Aroda, Vanita
Year: 2015
Citation:
  • Unpublished 2015 Sep 14
Institution:
  • MedStar Health Research Institute
Form of publication:
  • Conference
All authors:
  • Aroda V, Horowtiz M, Rayner C, Hardy E, et al
Local accession number:
  • 2015_3
5.
Older people with type 2 diabetes: glycaemic control and hypoglycaemia risk with new insulin glargine 300 U/Ml (Gla-300) MedStar authors:
  • Aroda, Vanita
Year: 2015
Citation:
  • Unpublished 2015 Sep 14
Institution:
  • MedStar Health Research Institute
Form of publication:
  • Conference
All authors:
  • Sinclair AJ, Aroda V, Merino-Trigo A, Grisoni M, et al
Local accession number:
  • 2015_3
6.
Liraglutide 3.0 mg efficacy and safety by baseline BMI in the SCALE Diabetes Trial: post-hoc analysis MedStar authors:
  • Aroda, Vanita
Year: 2015
Citation:
  • Unpublished 2015 Sep 14
Institution:
  • MedStar Health Research Institute
Form of publication:
  • Conference
All authors:
  • Hemmingsson JU, Aroda V, Davies M, Bays H, et al
Local accession number:
  • 2015_3
7.
Upper and/or lower GI adverse events with long- vs short-acting GLP-1 receptor agonists: incidence, co-incidence, effects on HbA1c and weight MedStar authors:
  • Aroda, Vanita
Year: 2015
Citation:
  • Unpublished 2015 Sep 14
Institution:
  • MedStar Health Research Institute
Form of publication:
  • Conference
All authors:
  • Aroda V, Horowtiz M, Rayner C, Hardy E, et al
Local accession number:
  • 2015_3
8.
Older people with type 2 diabetes: glycaemic control and hypoglycaemia risk with new insulin glargine 300 U/Ml (Gla-300) MedStar authors:
  • Aroda, Vanita
Year: 2015
Citation:
  • Unpublished 2015 Sep 14
Institution:
  • MedStar Health Research Institute
Form of publication:
  • Conference
All authors:
  • Sinclair AJ, Aroda V, Merino-Trigo A, Grisoni M, et al
Local accession number:
  • 2015_3
Pages

Powered by Koha